Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 48% ± 12% | |
lung | 18 studies | 46% ± 18% | |
intestine | 10 studies | 51% ± 20% | |
kidney | 7 studies | 43% ± 17% | |
bone marrow | 7 studies | 33% ± 19% | |
brain | 6 studies | 28% ± 8% | |
eye | 6 studies | 37% ± 17% | |
uterus | 6 studies | 66% ± 12% | |
placenta | 4 studies | 50% ± 15% | |
heart | 4 studies | 33% ± 14% | |
skin | 4 studies | 53% ± 24% | |
breast | 4 studies | 53% ± 7% | |
liver | 4 studies | 49% ± 15% | |
ovary | 3 studies | 68% ± 13% | |
adrenal gland | 3 studies | 34% ± 6% | |
lymph node | 3 studies | 47% ± 32% | |
prostate | 3 studies | 30% ± 7% | |
adipose | 3 studies | 47% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 27648.14 | 457 / 459 | 98% | 1079.25 | 1099 / 1118 |
ovary | 100% | 25850.07 | 180 / 180 | 95% | 758.40 | 408 / 430 |
lung | 99% | 17447.88 | 574 / 578 | 93% | 732.25 | 1075 / 1155 |
uterus | 100% | 41584.99 | 170 / 170 | 91% | 1090.38 | 419 / 459 |
adrenal gland | 100% | 14070.05 | 258 / 258 | 91% | 801.58 | 209 / 230 |
skin | 88% | 36414.59 | 1586 / 1809 | 99% | 2601.38 | 468 / 472 |
bladder | 95% | 20560.95 | 20 / 21 | 85% | 816.83 | 428 / 504 |
prostate | 98% | 17698.40 | 241 / 245 | 80% | 344.85 | 400 / 502 |
intestine | 85% | 19369.26 | 822 / 966 | 83% | 517.46 | 436 / 527 |
kidney | 73% | 5551.91 | 65 / 89 | 88% | 662.76 | 792 / 901 |
thymus | 71% | 5093.63 | 465 / 653 | 86% | 673.25 | 522 / 605 |
esophagus | 74% | 14887.41 | 1074 / 1445 | 72% | 481.68 | 131 / 183 |
stomach | 55% | 8415.19 | 197 / 359 | 85% | 506.34 | 243 / 286 |
brain | 63% | 5304.39 | 1674 / 2642 | 72% | 589.81 | 509 / 705 |
adipose | 100% | 34328.47 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 735.85 | 29 / 29 |
blood vessel | 100% | 31531.50 | 1332 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 6% | 406.79 | 20 / 328 | 93% | 1115.53 | 166 / 178 |
heart | 99% | 15040.56 | 849 / 861 | 0% | 0 | 0 / 0 |
muscle | 95% | 11923.55 | 763 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 923.32 | 42 / 45 |
spleen | 92% | 8301.88 | 221 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 13818.15 | 851 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 581.25 | 70 / 80 |
liver | 15% | 963.73 | 34 / 226 | 62% | 350.34 | 253 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0031295 | Biological process | T cell costimulation |
GO_0046598 | Biological process | positive regulation of viral entry into host cell |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0045445 | Biological process | myoblast differentiation |
GO_2001200 | Biological process | positive regulation of dendritic cell differentiation |
GO_0002317 | Biological process | plasma cell differentiation |
GO_0006915 | Biological process | apoptotic process |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0070062 | Cellular component | extracellular exosome |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_1990724 | Cellular component | galectin complex |
GO_0003723 | Molecular function | RNA binding |
GO_0043236 | Molecular function | laminin binding |
GO_0030395 | Molecular function | lactose binding |
GO_0005515 | Molecular function | protein binding |
Gene name | LGALS1 |
Protein name | Lectin, galactoside-binding, soluble, 1 Galectin 1 Galectin-1 (Gal-1) (14 kDa laminin-binding protein) (HLBP14) (14 kDa lectin) (Beta-galactoside-binding lectin L-14-I) (Galaptin) (HBL) (HPL) (Lactose-binding lectin 1) (Lectin galactoside-binding soluble 1) (Putative MAPK-activating protein PM12) (S-Lac lectin 1) |
Synonyms | |
Description | FUNCTION: Lectin that binds beta-galactoside and a wide array of complex carbohydrates. Plays a role in regulating apoptosis, cell proliferation and cell differentiation. Inhibits CD45 protein phosphatase activity and therefore the dephosphorylation of Lyn kinase. Strong inducer of T-cell apoptosis. . |
Accessions | F8WCQ5 P09382 ENST00000215909.10 ENST00000425542.5 ENST00000454173.1 A0A0B6XK00 F8WEI7 |